Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cancer Targeted Technology LLC
DescriptionSmall molecule inhibitor of prostate-specific membrane antigen (PSMA; FOLH1; GCPII) PET imaging agent
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationCancer, Diagnostic
Indication DetailsDetect prostate tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today